Clinical Trial Update: Safety and Efficacy of Metronomic Cyclophosphamide, Metformin and Olaparib in Endometrial Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating the safety and anti-tumor activity of metronomic cyclophosphamide, metformin, and olaparib in patients with recurrent end…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Olaparib (Olaparib)
• metformin (metformin)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Recurrent Endometrial Cancer | Phase 1, Phase 2 | Status: COMPLETED